Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

32.60
Delayed Data
As of Apr 28
 -0.60 / -1.81%
Today’s Change
14.14
Today|||52-Week Range
33.65
+29.11%
Year-to-Date

Today’s Trading

Previous close33.20
Today’s open33.30
Day’s range32.10 - 33.30
Volume378,057
Average volume (3 months)544,706
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+528.57%
Earnings growth (this year)-26.36%
Earnings growth (next 5 years)+50.00%
Revenue growth (last year)+48.87%
P/E ratio18.5
Price/Sales6.07
Price/Book8.50

Competitors

 Today’s
change
Today’s
% change
LXRXLexicon Pharmaceutic...0.000.00%
PBYIPuma Biotechnology I...+0.65+1.63%
AERIAerie Pharmaceutical...-0.45-1.01%
ARRYArray Biopharma Inc-0.03-0.34%
Data as of 4:14pm ET, 04/28/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)$0.24
Annual revenue (last year)$215.0M
Annual profit (last year)$91.2M
Net profit margin42.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts